{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:50:56Z","timestamp":1790970656923,"version":"4.1.0"},"reference-count":61,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Treatment of primary hyperparathyroidism (PHPT) and secondary hyperparathyroidism due to idiopathic hypercalciuria (SHPT-IH) is markedly different. Robust diagnostic tools to differentiate between both entities are however lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Evaluate the thiazide challenge test (TCT) in clinical practice, its aid in clinical decision making, and evaluate the accuracy (sensitivity, specificity) and potentially useful parameters of the TCT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Monocentric observational retrospective cohort study from January 2017 to November 2023 in an outpatient Endocrinology department, Ghent University Hospital (Belgium). Twenty-five adult patients with hypercalciuria, elevated parathyroid hormone (PTH), and high-normal or elevated serum calcium underwent a TCT. Outcome measures were serum, urinary biochemical parameters before and after testing, clinical and imaging outcomes, treatment, and follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with a TCT-based working diagnosis of PHPT show greater increases in albumin-adjusted calcium and total serum calcium concentration than patients with SHPT-IH (+0.11 \u00b1 0.10 vs +0.0071 \u00b1 0.10\u2005mmol\/L; P = .025 and +0.14 \u00b1 0.12 vs +0.012 \u00b1 0.15\u2005mmol\/L; P = .024, respectively). The TCT-based working diagnosis of PHPT has a sensitivity of 81.8%, a specificity of 77.8%, and a likelihood ratio of 3.68 of estimating a correct final diagnosis. Urinary calcium excretion, PTH, calcium\u2013phosphorous ratio, PTH inhibition rate, and the parathyroid function index do not differ significantly in patients with PHPT compared with those with SHPT-IH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The TCT aids in discriminating patients with PHPT from those with SHPT-IH based on a rise in serum calcium. Other parameters are not different between both groups. Larger prospective trials are necessary to further define the diagnostic potential of the TCT, its most appropriate biochemical outcome variables, and decision cut-offs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae239","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T03:10:50Z","timestamp":1712891450000},"page":"e783-e790","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the Thiazide Challenge Test to Differentiate Primary From Hypercalciuria-Related Hyperparathyroidism"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5477-788X","authenticated-orcid":false,"given":"Ewout","family":"Verly","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital , 9000 Ghent ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1584-4965","authenticated-orcid":false,"given":"Bruno","family":"Lapauw","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital , 9000 Ghent ,","place":["Belgium"]},{"name":"Department of Internal Medicine and Pediatrics, Ghent University , 9000 Ghent ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2451-9419","authenticated-orcid":false,"given":"Charlotte","family":"Verroken","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Unit for Osteoporosis and Metabolic Bone Diseases, Ghent University Hospital , 9000 Ghent ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,4,12]]},"reference":[{"issue":"9684","key":"2025021815505139900_dgae239-B1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"2025021815505139900_dgae239-B2","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025021815505139900_dgae239-B3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/archinte.1969.00300200001001","article-title":"Parathyroid gland metabolism","volume":"124","author":"Raisz","year":"1969","journal-title":"Arch Intern Med"},{"issue":"2","key":"2025021815505139900_dgae239-B4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.2008-1758","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Eastell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"2025021815505139900_dgae239-B5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM196605262742105","article-title":"The study of hyperparathyroidism at the Massachusetts General Hospital","volume":"274","author":"Cope","year":"1966","journal-title":"N Engl J Med"},{"issue":"5","key":"2025021815505139900_dgae239-B6","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ahj.2013.02.014","article-title":"Parathyroid hormone and cardiovascular disease events: a systematic review and meta-analysis of prospective studies","volume":"165","author":"van Ballegooijen","year":"2013","journal-title":"Am Heart J"},{"issue":"11","key":"2025021815505139900_dgae239-B7","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1002\/jbmr.4679","article-title":"Classical and nonclassical manifestations of primary hyperparathyroidism","volume":"37","author":"El-Hajj Fuleihan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025021815505139900_dgae239-B8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025021815505139900_dgae239-B9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"issue":"2","key":"2025021815505139900_dgae239-B10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0002-9343(93)90260-V","article-title":"Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy","volume":"95","author":"Stefenelli","year":"1993","journal-title":"Am J Med"},{"issue":"3","key":"2025021815505139900_dgae239-B11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3803\/EnM.2021.1061","article-title":"Normocalcemic primary hyperparathyroidism: need for a standardized clinical approach","volume":"36","author":"Zavatta","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"2025021815505139900_dgae239-B12","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/archsurg.143.3.260","article-title":"The changing presentation of hyperparathyroidism over 3 decades","volume":"143","author":"Mazzaglia","year":"2008","journal-title":"Arch Surg"},{"issue":"2","key":"2025021815505139900_dgae239-B13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","article-title":"Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Silverberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025021815505139900_dgae239-B14","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","article-title":"The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure","volume":"70","author":"Parisien","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025021815505139900_dgae239-B15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.surg.2020.07.010","article-title":"Parathyroidectomy improves hypercalciuria in patients with primary hyperparathyroidism","volume":"168","author":"Shariq","year":"2020","journal-title":"Surgery"},{"issue":"2","key":"2025021815505139900_dgae239-B16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/end.2008.0567","article-title":"Differentiating primary from secondary hyperparathyroidism in stone patients: the \u201cthiazide challenge\u201d","volume":"23","author":"Eisner","year":"2009","journal-title":"J Endourol"},{"issue":"10","key":"2025021815505139900_dgae239-B17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"11","key":"2025021815505139900_dgae239-B18","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2025021815505139900_dgae239-B19","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025021815505139900_dgae239-B20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jocd.2012.12.001","article-title":"Normocalcemic primary hyperparathyroidism","volume":"16","author":"Cusano","year":"2013","journal-title":"J Clin Densitom"},{"issue":"8","key":"2025021815505139900_dgae239-B21","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025021815505139900_dgae239-B22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2025021815505139900_dgae239-B23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0272-6386(12)80977-2","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"23","author":"Slatopolsky","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"2025021815505139900_dgae239-B24","doi-asserted-by":"crossref","first-page":"dgaa174","DOI":"10.1210\/clinem\/dgaa174","article-title":"Clinical, biochemical, and radiological profile of normocalcemic primary hyperparathyroidism","volume":"105","author":"Palermo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025021815505139900_dgae239-B25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00774-005-0647-y","article-title":"Causes of secondary hyperparathyroidism in a healthy population: the Troms\u00f8 study","volume":"24","author":"Saleh","year":"2006","journal-title":"J Bone Miner Metab"},{"issue":"2","key":"2025021815505139900_dgae239-B26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2013an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"issue":"2","key":"2025021815505139900_dgae239-B27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12020-021-02845-4","article-title":"A practical approach to normocalcemic primary hyperparathyroidism","volume":"74","author":"Mu\u00f1oz de Nova","year":"2021","journal-title":"Endocrine"},{"issue":"1","key":"2025021815505139900_dgae239-B28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1172\/JCI107156","article-title":"Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria","volume":"52","author":"Coe","year":"1973","journal-title":"J Clin Invest"},{"issue":"5735","key":"2025021815505139900_dgae239-B29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/bmj.4.5735.582","article-title":"Idiopathic hypercalciuria and hyperparathyroidism","volume":"4","author":"Adams","year":"1970","journal-title":"Br Med J"},{"issue":"2","key":"2025021815505139900_dgae239-B30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0026-0495(78)90158-0","article-title":"Selective effects of thiazide on intestinal absorption of calcium and adsorptive and renal hypercalciurias","volume":"27","author":"Barilla","year":"1978","journal-title":"Metabolism"},{"issue":"7","key":"2025021815505139900_dgae239-B31","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2014-4548","article-title":"Hypercalciuria may persist after successful parathyroid surgery and it is associated with parathyroid hyperplasia","volume":"100","author":"Palmieri","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025021815505139900_dgae239-B32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00240-013-0568-5","article-title":"Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones","volume":"41","author":"Wolfgram","year":"2013","journal-title":"Urolithiasis"},{"issue":"1","key":"2025021815505139900_dgae239-B33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0026-0495(80)90091-8","article-title":"Selective effects of thiazide therapy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias","volume":"29","author":"Zerwekh","year":"1980","journal-title":"Metabolism"},{"issue":"4","key":"2025021815505139900_dgae239-B34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ando.2022.05.003","article-title":"Calcium homeostasis and hyperparathyroidism: nephrologic and endocrinologic points of view","volume":"83","author":"Lemoine","year":"2022","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"2025021815505139900_dgae239-B35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03347852","article-title":"The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption","volume":"19","author":"Farias","year":"1996","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2025021815505139900_dgae239-B36","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jc.2015-3964","article-title":"Thiazide-associated hypercalcemia: incidence and association with primary hyperparathyroidism over two decades","volume":"101","author":"Griebeler","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025021815505139900_dgae239-B37","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ando.2015.03.005","article-title":"How to manage an isolated elevated PTH?","volume":"76","author":"Souberbielle","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"2025021815505139900_dgae239-B38","first-page":"G575","article-title":"Effects of chlorothiazide on 1,25-dihydroxyvitamin D3, parathyroid hormone, and intestinal calcium absorption in the rat","volume":"242","author":"Favus","year":"1982","journal-title":"Am J Physiol"},{"issue":"5","key":"2025021815505139900_dgae239-B39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00000658-197705000-00003","article-title":"The surgical treatment of primary hyperparathyroidism: a 20 year experience","volume":"185","author":"Coffey","year":"1977","journal-title":"Ann Surg"},{"issue":"4","key":"2025021815505139900_dgae239-B40","doi-asserted-by":"crossref","first-page":"bvad013","DOI":"10.1210\/jendso\/bvad013","article-title":"The eucalcemic patient with elevated parathyroid hormone levels","volume":"7","author":"Shaker","year":"2023","journal-title":"J Endocr Soc"},{"issue":"2","key":"2025021815505139900_dgae239-B41","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025021815505139900_dgae239-B42","first-page":"F415","article-title":"Physiological basis for absorptive and renal hypercalciurias","volume":"237","author":"Pak","year":"1979","journal-title":"Am J Physiol"},{"issue":"11","key":"2025021815505139900_dgae239-B43","doi-asserted-by":"crossref","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"2025021815505139900_dgae239-B44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euf.2020.12.019","article-title":"Metabolic evaluation: place of the calcium load test: how, when, for whom, and why?","volume":"7","author":"Keller","year":"2021","journal-title":"Eur Urol Focus"},{"issue":"12","key":"2025021815505139900_dgae239-B45","first-page":"5445","article-title":"Clinical value of calcium load test in differential diagnosis of different types of hyperparathyroidism","volume":"7","author":"Zhu","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2025021815505139900_dgae239-B46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12902-019-0487-8","article-title":"New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study","volume":"20","author":"Guo","year":"2020","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"2025021815505139900_dgae239-B47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12020-020-02276-7","article-title":"The calcium-to-phosphorous (Ca\/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study","volume":"68","author":"Madeo","year":"2020","journal-title":"Endocrine"},{"issue":"2","key":"2025021815505139900_dgae239-B48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jbm4.10019","article-title":"Serum calcium to phosphorous (Ca\/P) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism","volume":"2","author":"Madeo","year":"2018","journal-title":"JBMR Plus"},{"issue":"10-11","key":"2025021815505139900_dgae239-B49","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.clinbiochem.2011.03.142","article-title":"PTH inhibition rate is useful in the detection of early-stage primary hyperparathyroidism","volume":"44","author":"Zhao","year":"2011","journal-title":"Clin Biochem"},{"issue":"3","key":"2025021815505139900_dgae239-B50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0194599820983728","article-title":"Normocalcemic and normohormonal primary hyperparathyroidism: laboratory values and end-organ effects","volume":"165","author":"Hollowoa","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"4","key":"2025021815505139900_dgae239-B51","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1210\/jc.2016-2481","article-title":"Thiazide treatment in primary hyperparathyroidism-a new indication for an old medication?","volume":"102","author":"Tsvetov","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2025021815505139900_dgae239-B52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM197503062921002","article-title":"A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias","volume":"292","author":"Pak","year":"1975","journal-title":"N Engl J Med"},{"issue":"4","key":"2025021815505139900_dgae239-B53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14341\/probl13150","article-title":"The short test with hydrochlorothiazide in differential diagnosis between primary normocalcemic and secondary hyperparathyroidism for inpatient treatment","volume":"68","author":"Eremkina","year":"2022","journal-title":"Probl Endokrinol (Mosk)"},{"issue":"2","key":"2025021815505139900_dgae239-B54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/cen.13046","article-title":"The influence of thiazide intake on calcium and parathyroid hormone levels in patients with primary hyperparathyroidism","volume":"85","author":"Riss","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2025021815505139900_dgae239-B55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00240-022-01355-w","article-title":"How useful is an oral calcium load test for diagnosing recurrent calcium stone formers?","volume":"50","author":"Tostivint","year":"2022","journal-title":"Urolithiasis"},{"issue":"12","key":"2025021815505139900_dgae239-B56","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5694\/j.1326-5377.1986.tb112347.x","article-title":"Complications of thiazide diuretic therapy: an update","volume":"144","author":"Field","year":"1986","journal-title":"Med J Aust"},{"issue":"1","key":"2025021815505139900_dgae239-B57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.HYP.0000103632.19915.0E","article-title":"Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability","volume":"43","author":"Carter","year":"2004","journal-title":"Hypertension"},{"issue":"4","key":"2025021815505139900_dgae239-B58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamainternmed.2019.7454","article-title":"Comparison of cardiovascular and safety outcomes of chlorthalidone vs hydrochlorothiazide to treat hypertension","volume":"180","author":"Hripcsak","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"4","key":"2025021815505139900_dgae239-B59","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.eururo.2014.10.029","article-title":"Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines","volume":"67","author":"Skolarikos","year":"2015","journal-title":"Eur Urol"},{"issue":"6","key":"2025021815505139900_dgae239-B60","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.beem.2018.12.003","article-title":"Epidemiology of parathyroid disorders","volume":"32","author":"Rao","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2025021815505139900_dgae239-B61","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae239\/57330717\/dgae239.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/3\/e783\/57330717\/dgae239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/3\/e783\/57330717\/dgae239.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:12:30Z","timestamp":1739895150000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/3\/e783\/7644366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,12]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,12]]},"published-print":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae239","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,4,12]]}}}